Effectiveness of MT regimen in treatment of acute monocytic leukemia and its relationship with karyotype
10.3760/cma.j.issn.1009-9921.2011.06.010
- VernacularTitle:MT方案治疗急性单核细胞白血病的疗效及其与染色体核型的关系
- Author:
Wenjian MO
;
Ming ZHOU
;
Tingfen DENG
;
Qinghua DU
;
Qingshan LI
;
Shilin XU
- Publication Type:Journal Article
- Keywords:
Leukemia,monocytic,acute;
Drug combination chemotherapy;
Karyotype analysis
- From:
Journal of Leukemia & Lymphoma
2011;20(6):370-372,375
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the effectiveness and side effect of MT regimen (mitoxantrone plus teniposide) in inductive chemotherapy and explore the relationship between the effectiveness and karyotype. Methods 33 patients with acute monocytic leukemia were divided into two groups according to the treatment history or risk status according to cytogenetics MRC criteria. Group A (n=23) and B (n=10) were primary treatment and no remission following one course of DA (daunorubicin plus cytarabine) or HDA (Harringtonine,daunorubicin plus cytarabine) regimen,respectively. According to MRC criteria,group C (n=29) and D (n=4) were intermediate and adverse group. All the cases received two courses MT regimen chemotherapies to induce remission. The results and side effects were analysed. Results The complete remission rate and effective rate in group A and B were 83 % (19/23) and 60 % (6/10),91 % (21/23) and 70 % (7/10) respectively. The complete remission rate and effective rate in group C and D was 83 % (24/29) and 25 % (1/4),88 % (26/29) and 50 % (2/4) respectively. In complex cytogenetic group and 11q23 abnormal without complex cytogenetic group,CR rate was 0 (0/3) and 100 % (4/4). The time point,count of WBC nadir and the duration of WBC were less than 1×109/L is (7±3) day after chemotherapy,(0.4±0.2)×l09/L,(8±5) day. Chemotherapy related mortality was 0. Conclusion MT regimen was highly effective and safe in inducing remission in acute monocytic leukemia,including the cases which achieved no remission following one course of DA or HDA regimen. The effectiveness of MT regimen relates to the cytogenetics. MT regimen may be highly effective in cases with 11q23 abnormal and poor effective in cases with complex cytogenetic.
